216 related articles for article (PubMed ID: 17588166)
21. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.
Aoki Y; Niihori T; Narumi Y; Kure S; Matsubara Y
Hum Mutat; 2008 Aug; 29(8):992-1006. PubMed ID: 18470943
[TBL] [Abstract][Full Text] [Related]
22. Lead acetate induces EGFR activation upstream of SFK and PKCalpha linkage to the Ras/Raf-1/ERK signaling.
Wang CY; Wang YT; Tzeng DW; Yang JL
Toxicol Appl Pharmacol; 2009 Mar; 235(2):244-52. PubMed ID: 19133285
[TBL] [Abstract][Full Text] [Related]
23. PIK3CA, HRAS and KRAS gene mutations in human penile cancer.
Andersson P; Kolaric A; Windahl T; Kirrander P; Söderkvist P; Karlsson MG
J Urol; 2008 May; 179(5):2030-4. PubMed ID: 18355852
[TBL] [Abstract][Full Text] [Related]
24. Missense mutation of the MET gene detected in human glioma.
Moon YW; Weil RJ; Pack SD; Park WS; Pak E; Pham T; Karkera JD; Kim HK; Vortmeyer AO; Fuller BG; Zhuang Z
Mod Pathol; 2000 Sep; 13(9):973-7. PubMed ID: 11007037
[TBL] [Abstract][Full Text] [Related]
25. CNS germinomas are characterized by global demethylation, chromosomal instability and mutational activation of the Kit-, Ras/Raf/Erk- and Akt-pathways.
Schulte SL; Waha A; Steiger B; Denkhaus D; Dörner E; Calaminus G; Leuschner I; Pietsch T
Oncotarget; 2016 Aug; 7(34):55026-55042. PubMed ID: 27391150
[TBL] [Abstract][Full Text] [Related]
26. Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas.
Lo HW
Curr Cancer Drug Targets; 2010 Dec; 10(8):840-8. PubMed ID: 20718706
[TBL] [Abstract][Full Text] [Related]
27. Comparative transcriptome and proteome analysis of Ha-ras and B-raf mutated mouse liver tumors.
Rignall B; Ittrich C; Krause E; Appel KE; Buchmann A; Schwarz M
J Proteome Res; 2009 Aug; 8(8):3987-94. PubMed ID: 19476384
[TBL] [Abstract][Full Text] [Related]
28. KSR and CNK: two scaffolds regulating RAS-mediated RAF activation.
Clapéron A; Therrien M
Oncogene; 2007 May; 26(22):3143-58. PubMed ID: 17496912
[TBL] [Abstract][Full Text] [Related]
29. Activated Ras enhances insulin-like growth factor I induction of vascular endothelial growth factor in prostate epithelial cells.
Stearns M; Tran J; Francis MK; Zhang H; Sell C
Cancer Res; 2005 Mar; 65(6):2085-8. PubMed ID: 15781617
[TBL] [Abstract][Full Text] [Related]
30. Frequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma.
Wong KY; Yao Q; Yuan LQ; Li Z; Ma ESK; Chim CS
Sci Rep; 2018 Sep; 8(1):13522. PubMed ID: 30201956
[TBL] [Abstract][Full Text] [Related]
31. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis.
Buchmann A; Karcier Z; Schmid B; Strathmann J; Schwarz M
Mutat Res; 2008 Feb; 638(1-2):66-74. PubMed ID: 17928010
[TBL] [Abstract][Full Text] [Related]
32. Molecular cloning and characterization of Ras- and Raf-homologues from the fox-tapeworm Echinococcus multilocularis.
Spiliotis M; Tappe D; Brückner S; Mösch HU; Brehm K
Mol Biochem Parasitol; 2005 Feb; 139(2):225-37. PubMed ID: 15664657
[TBL] [Abstract][Full Text] [Related]
33. Genetic alterations in brain tumors following 1,3-butadiene exposure in B6C3F1 mice.
Kim Y; Hong HH; Lachat Y; Clayton NP; Devereux TR; Melnick RL; Hegi ME; Sills RC
Toxicol Pathol; 2005; 33(3):307-12. PubMed ID: 15814359
[TBL] [Abstract][Full Text] [Related]
34. Stabilization of physical RAF/14-3-3 interaction by cotylenin A as treatment strategy for RAS mutant cancers.
Molzan M; Kasper S; Röglin L; Skwarczynska M; Sassa T; Inoue T; Breitenbuecher F; Ohkanda J; Kato N; Schuler M; Ottmann C
ACS Chem Biol; 2013 Sep; 8(9):1869-75. PubMed ID: 23808890
[TBL] [Abstract][Full Text] [Related]
35. Novel RAF Fusions in Pediatric Low-Grade Gliomas Demonstrate MAPK Pathway Activation.
Lind KT; Chatwin HV; DeSisto J; Coleman P; Sanford B; Donson AM; Davies KD; Willard N; Ewing CA; Knox AJ; Mulcahy Levy JM; Gilani A; Green AL
J Neuropathol Exp Neurol; 2021 Dec; 80(12):1099-1107. PubMed ID: 34850053
[TBL] [Abstract][Full Text] [Related]
36. Activated Kras, but not Hras or Nras, may initiate tumors of endodermal origin via stem cell expansion.
Quinlan MP; Quatela SE; Philips MR; Settleman J
Mol Cell Biol; 2008 Apr; 28(8):2659-74. PubMed ID: 18268007
[TBL] [Abstract][Full Text] [Related]
37. Implications of mitogen-activated protein kinase signaling in glioma.
Pandey V; Bhaskara VK; Babu PP
J Neurosci Res; 2016 Feb; 94(2):114-27. PubMed ID: 26509338
[TBL] [Abstract][Full Text] [Related]
38. Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation.
Robinson JP; VanBrocklin MW; Guilbeault AR; Signorelli DL; Brandner S; Holmen SL
Oncogene; 2010 Jan; 29(3):335-44. PubMed ID: 19855433
[TBL] [Abstract][Full Text] [Related]
39. Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAF.
Hechtman JF; Zehir A; Yaeger R; Wang L; Middha S; Zheng T; Hyman DM; Solit D; Arcila ME; Borsu L; Shia J; Vakiani E; Saltz L; Ladanyi M
Mol Cancer Res; 2016 Mar; 14(3):296-301. PubMed ID: 26660078
[TBL] [Abstract][Full Text] [Related]
40. Raf-interactome in tuning the complexity and diversity of Raf function.
An S; Yang Y; Ward R; Liu Y; Guo XX; Xu TR
FEBS J; 2015 Jan; 282(1):32-53. PubMed ID: 25333451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
